Aegon N.V. Stock Deutsche Boerse AG
Equities
AEND
NL0000303709
Life & Health Insurance
Sales 2024 * | 12.94B 13.86B | Sales 2025 * | 14.15B 15.15B | Capitalization | 10.11B 10.82B |
---|---|---|---|---|---|
Net income 2024 * | 1.19B 1.27B | Net income 2025 * | 1.31B 1.4B | EV / Sales 2024 * | 1.68 x |
Net Debt 2024 * | 11.67B 12.5B | Net Debt 2025 * | 1.95B 2.09B | EV / Sales 2025 * | 0.85 x |
P/E ratio 2024 * |
7.97
x | P/E ratio 2025 * |
6.97
x | Employees | - |
Yield 2024 * |
6.17% | Yield 2025 * |
6.93% | Free-Float | 78.28% |
Latest transcript on Aegon N.V.
1st Jan change | Capi. | |
---|---|---|
+3.66% | 72.1B | |
+8.25% | 50.75B | |
+6.14% | 49.91B | |
+24.42% | 47.64B | |
+13.00% | 42.08B | |
+17.16% | 33.02B | |
-2.39% | 28.42B | |
-9.01% | 27.19B | |
+28.96% | 26.64B |